NeoGenomics (NASDAQ:NEO) Stock Rating Lowered by StockNews.com
NeoGenomics (NASDAQ:NEO – Get Rating) was downgraded by StockNews.com from a “hold” rating to a “sell” rating in a note issued to investors on Friday. Several other equities analysts have also recently weighed in on NEO. Benchmark raised NeoGenomics from a “hold” rating to a “buy” rating and set a $20.00 price target on the […]